Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Share News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 664.00
Bid: 660.00
Ask: 668.00
Change: 6.00 (0.91%)
Spread: 8.00 (1.212%)
Open: 662.00
High: 672.00
Low: 662.00
Prev. Close: 658.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

International Biotechnology Trust Net Asset Value Rises In Half-Year

Tue, 22nd Apr 2014 11:52

LONDON (Alliance News) - International Biotechnology Trust PLC said Tuesday that it had seen its net asset value per share rise in the half-year to February 28, 2014, although it under-performed the NASDAQ Biotechnology Index.

The trust posted a total return on net asset value per share of 21.5%, under-performing The NASDAQ Biotechnology Index which rose 26.6%. However it out-performed the S&P 500 and the FTSE All-Share index which rose 6.5% and 8.8%, respectively.

Its quoted portfolio rose 25.7%, and its unquoted portfolio grew 4.2%, although both were hit by currency movements resulting in an overall loss of GBP17.1 million.

The quoted portfolio was boosted by strong drug launches from Gilead Sciences Inc and Biogen Idec Inc.

However, Aegerion Pharmaceuticals Inc's launch of LDL-Cholesterol reducing treatment Juxtapid failed to meet expectations and Ariad Pharmaceuticals Incs' oncology drug Iclusig was suspended by the US Food and Drug administration over concerns of serious side effects.

The unquoted portfolio was boosted by the initial public offering of Ophthotech Corp on the NASDAQ in September, and the merger between TransEnterix Inc and SafeStitch Medical Inc to form a new over the counter drug company.

The trust said that concerns that the biotechnology sector would "grow too big and suffer the problems of the innovators of two decades ago, the pharmaceuticals sector, are fair." However, it noted that large biotech names have shifted towards acquiring new research and development innovations instead of expecting to continue generating new drugs from their internal research and development efforts.

"As these larger companies seek new innovative drugs from smaller, more nimble and often more innovative companies, we believe investors will benefit as the Company gives them exposure to the whole industry including private companies," the company said in a statement.

Shares in International Biotechnology Trust were trading up 5.7% at 270.53 pence Tuesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2014 08:17

STOCKS NEWS EUROPE-Biotechs hit as UK small caps fall

The FTSE Small Cap Index falls 0.4 percent while the junior-listed FTSE AIM All Share Index retreats 0.8 percent, broadly tracking a 0.8 percent drop on the blue-chip FTSE 100 index. The FTSE 250 mid-cap index falls 1.2 percent. Oxford BioMedica declines by 2.9 percent, as brokerage N

Read more
11 Apr 2014 05:13

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
10 Apr 2014 15:09

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
10 Apr 2014 05:09

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
9 Apr 2014 15:25

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
9 Apr 2014 05:30

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
8 Apr 2014 15:14

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
8 Apr 2014 05:12

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, April 8 
Netplay TV

Read more
7 Apr 2014 14:50

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, April 8 
Netplay TV

Read more
7 Apr 2014 05:28

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
4 Apr 2014 15:00

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
28 Feb 2014 17:00

DIRECTOR DEALINGS: International Biotechnology Trust Non-Executive, Partners Buy Shares

LONDON (Alliance News) - International Biotechnology Trust PLC said Friday that non-executive director Jim Horsburgh bought 5,000 shares at 330.94 pence each. Horsburgh's total holding following the transaction is 0.02%. Kate Bingham, a partner of the company's investment manager SV L

Read more
28 Feb 2014 16:18

XP Power board members reduce holdings

XP Power's Chairman, Larry Tracey, on Thursday sold 75,000 shares in the power supply solutions manufacturer. Tracey, who has held his current role since April 2002, disposed of the shares at 1,755p a time, generating a total of £1.3m. Fellow board member James Peters, a Non-Executive Director, t

Read more
13 Feb 2014 14:54

International Biotechnology Trust Ups Valuation Of Affinium Interest After Sale

LONDON (Alliance News) - The International Biotechnology Trust PLC Thursday said it has upped the valuation of its interest in Affinium Pharmaceuticals, an unquoted portfolio company, after it was sold to Debiopharm Group. In a statement, the trust said it upped the valuation of its interes

Read more

Quickpicks are a member only feature

Login to your account